Efficacy of fixed-dosing aflibercept for treating polypoidal choroidal vasculopathy: 1-year results of the VAULT study

PURPOSE: To investigate fixed-dosing aflibercept for treating polypoidal choroidal vasculopathy (PCV). METHODS: This phase IV, prospective, single-arm, interventional case series was conducted in eight centers. Forty treatment-naïve PCV patients were administered three monthly doses of intravitreal...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Joo Eun, Shin, Jae Pil, Kim, Hyun Woong, Chang, Woohyok, Kim, Yu Cheol, Lee, Sang Joon, Chung, In Young, Lee, Ji Eun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Retinal Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323470/
https://www.ncbi.nlm.nih.gov/pubmed/27628062
http://dx.doi.org/10.1007/s00417-016-3489-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323470/
https://www.ncbi.nlm.nih.gov/pubmed/27628062
http://dx.doi.org/10.1007/s00417-016-3489-5

Ejemplares similares